Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.55 -0.01 (-1.68%)
As of: Sep 30, 2026 · 3:13 PM EDT

Citius Pharmaceuticals (CTXR) Asset Utilization Ratio (2025 - 2026)

Updated

Citius Pharmaceuticals' (CTXR) Asset Utilization Ratio was 0.05 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 25.8% from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.49
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.47
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.52
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.44
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.53
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.40
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.58
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 0.47
10 Citius Pharmaceuticals 15.10 Mn 24.39 Mn 1.00 Mn 0.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Mar 31, 2026 0.04
Dec 31, 2025 0.03
API Access

Citius Pharmaceuticals Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CTXR&period=max&api_key=YOUR_API_KEY